Dergiler / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 2

Insulin/high-density lipoprotein cholesterol ratio: A newlydiscovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus

Sayfa
155–162
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The validity of two IR-related predictors in theabsence of metabolic syndrome confirmed the suggestion that the mechanism of IR-related HCV is different from that of the traditionalmetabolic syndrome.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: Insulin resistance (IR) is closely linked with chronic hepatitis C virus (HCV) and its complications, particularly hepaticfibrosis.
📊
Temel Bulgular & Veri:The aim of the present study was to investigate some biochemical markers that are potentially related to IR as predictors ofesophageal varices (EV) in patients with compensated HCV cirrhosis who do not have diabetes or metabolic syndrome.Materials and Methods: One hundred subjects without diabetes with compensated HCV-related cirrhosis who did not fulfill the diagnostic criteria of metabolic syndrome were subjected to clinical, laboratory, ultrasonographic, and endoscopic assessments.Results: EV were evident in 73 patients with lower platelet counts and high-density lipoprotein cholesterol (HDL-C) levels.
💡
Sonuç & Katkı:The validity of two IR-related predictors in theabsence of metabolic syndrome confirmed the suggestion that the mechanism of IR-related HCV is different from that of the traditionalmetabolic syndrome.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Insulin resistance (IR) is closely linked with chronic hepatitis C virus (HCV) and its complications, particularly hepaticfibrosis. The aim of the present study was to investigate some biochemical markers that are potentially related to IR as predictors ofesophageal varices (EV) in patients with compensated HCV cirrhosis who do not have diabetes or metabolic syndrome.Materials and Methods: One hundred subjects without diabetes with compensated HCV-related cirrhosis who did not fulfill the diagnostic criteria of metabolic syndrome were subjected to clinical, laboratory, ultrasonographic, and endoscopic assessments.Results: EV were evident in 73 patients with lower platelet counts and high-density lipoprotein cholesterol (HDL-C) levels. On the contrary, the fasting values of both insulin and glucose, the homeostatic model assessment for insulin resistance (HOMA-IR) score, and thebipolar diameter of the spleen of patients with EV were higher than those of other patients who were varices-free. Multivariate analysisconfirmed insulin/HDL-C ratio (P=0.01) and HOMA-IR score (P=0.039) as predictors for the presence of varices. The best cut-off valuesabove which the risk of the latter occurrence increased were 0.147 (sensitivity 89%) and 2.24 (sensitivity 72.6%) for both predictors,respectively.Conclusion: The present study recorded two valid predictors of HCV-related EV: HOMA-IR score and insulin/HDL-C ratio. The latter ismore sensitive and is likely more convenient in the case of individuals without diabetes. The validity of two IR-related predictors in theabsence of metabolic syndrome confirmed the suggestion that the mechanism of IR-related HCV is different from that of the traditionalmetabolic syndrome.

🔖

Bu Makaleye Atıf Yap

ELFAYOUMY, K. N., BERENGY, M. S., EMRAN, T. (2019). Insulin/high-density lipoprotein cholesterol ratio: A newlydiscovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 2, 155–162. https://ajindex.com/articles/409274

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013
  2. [CrossRef] Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004
  3. [CrossRef] Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008
  4. [CrossRef] Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study. Hypertension. 2005
  5. [CrossRef] Banerjee A, Meyer K, Mazumdar B, Ray RB, Ray R. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol 2010
  6. [CrossRef] Svegliati-Baroni G, De Minicis S, Marzioni M. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int 2008
  7. [CrossRef] de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005
  8. [CrossRef] de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008
  9. [CrossRef] Zaman A, Hapke RJ, Flora K, Rosen HR, Benner KG. Changing compliance to the American College of Gastroenterology guidelines for the management of variceal hemorrhage: a regional survey. Am J Gastroenterol 2004
  10. [CrossRef] Camma C, Petta S, Di Marco V et al. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology 2009
  11. [CrossRef] Hickman IJ, Powell EE, Prins JB, et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol 2003
  12. [CrossRef] Petit JM, Bour JB, Galland-Jos C, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001
  13. [CrossRef] El Ray A, Asselah T, Moucari R, et al. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian